BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 4336560)

  • 41. The effect of nucleotides and a nondialyzable factor on the hydrolysis of cyclic AMP by a cyclic nucleotide phosphodiesterase from beef heart.
    Goren EN; Rosen OM
    Arch Biochem Biophys; 1971 Feb; 142(2):720-3. PubMed ID: 4323731
    [No Abstract]   [Full Text] [Related]  

  • 42. Cyclic nucleotide-dependent protein kinase in the thyroid: partial purification and characterization.
    Rapoport B; DeGroot LJ
    Endocrinology; 1972 Nov; 91(5):1259-66. PubMed ID: 4342124
    [No Abstract]   [Full Text] [Related]  

  • 43. Stimulation of calcitonin release in vitro by purine and pyrimidine nucleotides.
    Bell NH
    Nat New Biol; 1973 Sep; 245(142):85-6. PubMed ID: 4354013
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization of a spectrophotometric assay for cAMP phosphodiesterase.
    Dedman JR; Means AR
    J Cyclic Nucleotide Res; 1977 Apr; 3(2):139-52. PubMed ID: 195985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of aging on the adenyl cyclase and phosphodiesterase activity of isolated fat cells of rat.
    Forn J; Schonhofer PS; Skidmore IF; Krishna G
    Biochim Biophys Acta; 1970 May; 208(2):304-9. PubMed ID: 4316097
    [No Abstract]   [Full Text] [Related]  

  • 46. Enzymology and genetic regulation of a cyclic nucleotide-binding phosphodiesterase-phosphomonoesterase from Aspergillus nidulans.
    Polya GM; Brownlee AG; Hynes MJ
    J Bacteriol; 1975 Nov; 124(2):693-703. PubMed ID: 241743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rat adrenal cyclic nucleotide-phosphodiesterase; inhibition by drugs known to affect steroidogenesis.
    Klotz U; Vapaatalo H; Stock K
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(4):376-85. PubMed ID: 4340534
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of thyroxine on the contents of cyclic AMP and on the activity of cyclic AMP phosphodiesterase in hepatocytes of the rat].
    Leoni S; Spagnuolo S
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1874-8. PubMed ID: 182190
    [No Abstract]   [Full Text] [Related]  

  • 49. An ultrastructural stereologic study of the effects of 3',5'-cyclic nucleotides on the zona glomerulosa of rat adrenal cortex.
    Nussdorfer GG; Mazzocchi G; Rebuffat P
    Endocrinology; 1974 Feb; 94(2):602-7. PubMed ID: 4359135
    [No Abstract]   [Full Text] [Related]  

  • 50. Two nucleic acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Nucleotide substrate and polynucleotide cofactor specificities.
    Paoletti E; Moss B
    J Biol Chem; 1974 May; 249(10):3281-6. PubMed ID: 4364422
    [No Abstract]   [Full Text] [Related]  

  • 51. An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase.
    Loten EG; Sneyd JG
    Biochem J; 1970 Nov; 120(1):187-93. PubMed ID: 4321931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclic 3',5'-nucleotide phosphodiesterase of Serratia marcescens.
    Okabayashi T; Ide M
    Biochim Biophys Acta; 1970 Oct; 220(1):116-23. PubMed ID: 4319606
    [No Abstract]   [Full Text] [Related]  

  • 53. Coupling of adenosine triphosphate formation in mitochondria to the formation of nucleoside triphosphates. Involvement of nucleoside diphosphokinase.
    Pedersen PL
    J Biol Chem; 1973 Jun; 248(11):3956-62. PubMed ID: 4708095
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on pyrazinoylguanidine. 4. Upregulation of phosphodiesterase activity in rat adipose tissue and downregulation of gluconeogenesis and adenosine 3',5'-monophosphate concentrations in perfused rat liver.
    A-Rahim YI; Rannels SL; Kimball SR; Beyer KH; Vesell ES
    Pharmacology; 1996 Oct; 53(4):211-8. PubMed ID: 8958559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline.
    Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
    Clin Exp Pharmacol Physiol; 1978; 5(5):535-9. PubMed ID: 215363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformations of cyclic 3',5'-nucleotides. Effect of the base on the synanti conformer distribution.
    Yathindra N; Sundaralingam M
    Biochem Biophys Res Commun; 1974 Jan; 56(1):119-26. PubMed ID: 4362936
    [No Abstract]   [Full Text] [Related]  

  • 57. Biochemical properties of cyclic nucleotide phosphodiesterase in metastasizing and nonmetastasizing rat mammary carcinomas.
    Chatterjee SK; Kim U
    J Natl Cancer Inst; 1976 Jan; 56(1):105-10. PubMed ID: 3660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The development of 3',5'-cyclic nucleotide phosphodiesterase in white and brown adipose tissue of the rat.
    Hahn P
    Experientia; 1970 Dec; 26(12):1300. PubMed ID: 4321669
    [No Abstract]   [Full Text] [Related]  

  • 59. Cyclic 3'5'adenosine monophosphate inhibition of sulfation factor activity.
    Rendall JL; Delcher HK; Lebovitz HE
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1425-9. PubMed ID: 4334980
    [No Abstract]   [Full Text] [Related]  

  • 60. An adenosine 3',5'-monophosphate-inhibited protein kinase from Physarum polycephalum.
    Kuehn GD
    J Biol Chem; 1971 Oct; 246(20):6366-9. PubMed ID: 4331389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.